Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels

Thrombosis and Haemostasis

Volumn 99, Issue 4, 2008, Pages 789-790

  Marchetti, Giovanna ^a   Lunghi, Barbara ^a   Mazzoni, Gianni ^a   Cini, Michela ^b   Legnani, Cristina ^b   Bernardi, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; ALLELE; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ADULT; FACTOR VIII; FACTOR XI; FEMALE; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 43749112028     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-12-0749     Document Type: Letter

References (11)

1. Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
2. Yang DT, Flanders MM, Kim H, et al. Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol 2006; 126: 411-415.
3. Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost 2007; 98: 84-89.
4. Gerdes VE, Kraaijenhagen RA, Vogels EW, et al. Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004; 2: 1015-1017.
5. Mitchell MJ, Dai L, Clarke JB, et al. Characterisation of five factor XI mutations. Thromb Haemost 2007; 97: 884-889.
6. Hill M, McLeod F, Franks H, et al. Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion. Br J Haematol 2005; 129: 825-829.
7. Knauer DJ, Majumdar D, Fong PC, et al. Serpin regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J Biol Chem 2000; 275: 37340-37346.
8. Morange PE, Tregouet DA, Frere C, et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol 2005; 128: 91-99.
9. Tirado I, Mateo J, Soria JM, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-474.
10. Marchetti G, Lunghi B, Legnani C, et al. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. Haematol 2006; 91: 1261-1263.
11. Glaser C, Schulz S, Handschug K, et al. Genetic and functional characteristics of the human in vivo LRP1/A2MR receptor suggested as a risk marker for Alzheimer's disease and other complex (degenerative) diseases. Neurosci Res 2004; 50: 85-101.